Cargando…

Alzheimer's Disease and Anesthesia

Cognitive disorders such as postoperative cognitive dysfunction, confusion, and delirium, are common following anesthesia in the elderly, with symptoms persisting for months or years in some patients. Alzheimer's disease (AD) patients appear to be particularly at risk of cognitive deterioration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papon, Marie-Amélie, Whittington, Robert A., El-Khoury, Noura B., Planel, Emmanuel
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034231/ https://www.ncbi.nlm.nih.gov/pubmed/21344011 http://dx.doi.org/10.3389/fnins.2010.00272

Ejemplares similares

Insulin dysfunction and Tau pathology
por: El Khoury, Noura B., et al.
Publicado: (2014)

Propofol Directly Increases Tau Phosphorylation
por: Whittington, Robert A., et al.
Publicado: (2011)

Insulin resistance and obesity: how do they affect tau pathology?
por: Gratuze, Maud, et al.
Publicado: (2013)

Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
por: Whittington, Robert A., et al.
Publicado: (2017)

Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation
por: Whittington, Robert A., et al.
Publicado: (2013)

Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice
por: Papon, Marie-Amélie, et al.
Publicado: (2013)

Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions
por: Petry, Franck R., et al.
Publicado: (2014)

Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation
por: Julien, Carl, et al.
Publicado: (2012)

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
por: Bretteville, Alexis, et al.
Publicado: (2012)

Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons
por: Rodriguez, Léa, et al.
Publicado: (2018)

Corrigendum: Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons
por: Rodriguez, Léa, et al.
Publicado: (2018)

MicroRNA-138 Overexpression Alters Aβ42 Levels and Behavior in Wildtype Mice
por: Boscher, Emmanuelle, et al.
Publicado: (2021)

Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats
por: Papon, Marie-Amélie, et al.
Publicado: (2020)

Blood-Based Kinase Assessments in Alzheimer’s Disease
por: Hugon, Jacques, et al.
Publicado: (2018)

Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology
por: Gratuze, Maud, et al.
Publicado: (2017)

Brain injury, neuroinflammation and Alzheimer's disease
por: Breunig, Joshua J., et al.
Publicado: (2013)

The Application of Unsupervised Clustering Methods to Alzheimer’s Disease
por: Alashwal, Hany, et al.
Publicado: (2019)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Of mice and men: neurogenesis, cognition and Alzheimer’s disease
por: Lazarov, Orly, et al.
Publicado: (2013)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Alzheimer's disease, anesthesia and the cholinergic system
por: Kapoor, Mukul C
Publicado: (2011)

Anesthesia and Alzheimer disease – Current perceptions()
por: Marques, Ana Filipa Vieira da Silva Ferreira, et al.
Publicado: (2017)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
por: Sontag, Jean-Marie, et al.
Publicado: (2014)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease
por: He, Qiling, et al.
Publicado: (2022)

Synapses, Microglia, and Lipids in Alzheimer’s Disease
por: Paasila, Patrick J., et al.
Publicado: (2022)

Assessing awareness in severe Alzheimer’s disease
por: Huntley, Jonathan, et al.
Publicado: (2023)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Music as a Mnemonic to Learn Gesture Sequences in Normal Aging and Alzheimer’s Disease
por: Moussard, Aline, et al.
Publicado: (2014)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation
por: Tournissac, Marine, et al.
Publicado: (2019)

Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
por: Yu, Lei, et al.
Publicado: (2021)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Decreased HHV-6 IgG in Alzheimer’s Disease
por: Westman, Gabriel, et al.
Publicado: (2017)

Rethinking Alzheimer’s Disease
por: de Mendonça, Alexandre
Publicado: (2012)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Propionate and Alzheimer’s Disease
por: Killingsworth, Jessica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_824fj8ea4ckslptl247u47k1e6